Scott J. Weir

5.2k total citations
106 papers, 2.2k citations indexed

About

Scott J. Weir is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Scott J. Weir has authored 106 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Molecular Biology, 22 papers in Oncology and 15 papers in Cancer Research. Recurrent topics in Scott J. Weir's work include Analytical Methods in Pharmaceuticals (11 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Scott J. Weir is often cited by papers focused on Analytical Methods in Pharmaceuticals (11 papers), Antibiotics Pharmacokinetics and Efficacy (9 papers) and Cardiac electrophysiology and arrhythmias (7 papers). Scott J. Weir collaborates with scholars based in United States, India and Canada. Scott J. Weir's co-authors include Subhash Padhyé, Mark G. Eller, Shrikant Anant, Anther Keung, M. Stoltz, Anuradha Roy, Tomoo Iwakuma, Vijay O. Bhargava, Tanya L. Russell and Dharmalingam Subramaniam and has published in prestigious journals such as Journal of the American Chemical Society, Circulation and Journal of Clinical Oncology.

In The Last Decade

Scott J. Weir

102 papers receiving 2.2k citations

Peers

Countries citing papers authored by Scott J. Weir

Since Specialization

Citations

This map shows the geographic impact of Scott J. Weir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott J. Weir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott J. Weir more than expected).

Fields of papers citing papers by Scott J. Weir

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott J. Weir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott J. Weir. The network helps show where Scott J. Weir may publish in the future.

Co-authorship network of co-authors of Scott J. Weir

This figure shows the co-authorship network connecting the top 25 collaborators of Scott J. Weir. A scholar is included among the top collaborators of Scott J. Weir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott J. Weir. Scott J. Weir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Selective targeting of IRAK1 attenuates low molecular weight hyaluronic acid-induced stemness and non-canonical STAT3 activation in epithelial ovarian cancer 2024 ·Cell Death and Disease ·David Standing, Prasad Dandawate, Sumedha Gunewardena, (unknown), Katherine F. Roby, Dineo Khabele, Andrea Jewell, Ossama Tawfik, Stefan H. Bossmann, Andrew K. Godwin, Scott J. Weir, Roy A. Jensen, Shrikant Anant	2
2	Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Krishan Gopal Jain, K. Venkateswara Swamy, Anup Kasi, Ameer Hamza, Shrikant Anant, Michael N. VanSaun, Scott J. Weir, Stefan H. Bossmann, Subhash Padhyé, Prasad Dandawate	12
3	Perinucleolar Compartment (PNC) Prevalence as an Independent Prognostic Factor in Pediatric Ewing Sarcoma: A Multi-Institutional Study 2023 ·Cancers ·Elizabeth M. Gonzalez, Atif Ahmed, (unknown), Katherine Chastain, (unknown), Marta Zapata‐Tarrés, Rocío Cárdenas‐Cardós, Liliana Velasco‐Hidalgo, (unknown), (unknown), (unknown), Alejandro Parrales, Tomoo Iwakuma, Midhat S. Farooqi, Brian Lee, Scott J. Weir, (unknown)	2
4	Fosciclopirox suppresses growth of high-grade urothelial cancer by targeting the γ-secretase complex 2021 ·Cell Death and Disease ·Scott J. Weir, Prasad Dandawate, David Standing, (unknown), Prabhu Ramamoorthy, (unknown), (unknown), Amanda E. Brinker, Benjamin L. Woolbright, (unknown), (unknown), William McCulloch, Michael Dalton, Gregory A. Reed, (unknown), Roy A. Jensen, John A. Taylor, Shrikant Anant	11
5	Honokiol Affects Stem Cell Viability by Suppressing Oncogenic YAP1 Function to Inhibit Colon Tumorigenesis 2021 ·Cells ·Dharmalingam Subramaniam, Sivapriya Ponnurangam, Satish Ramalingam, Deep Kwatra, Prasad Dandawate, Scott J. Weir, Shahid Umar, Roy A. Jensen, Shrikant Anant	11
6	Cucurbitacin B and I inhibits colon cancer growth by targeting the Notch signaling pathway 2020 ·Scientific Reports ·Prasad Dandawate, Dharmalingam Subramaniam, (unknown), David Standing, Balaji Krishnamachary, Gaurav Kaushik, Sufi M. Thomas, Animesh Dhar, Scott J. Weir, Roy A. Jensen, Shrikant Anant	59
7	Preclinical Pharmacokinetics of Fosciclopirox, a Novel Treatment of Urothelial Cancers, in Rats and Dogs 2019 ·Journal of Pharmacology and Experimental Therapeutics ·Scott J. Weir, (unknown), (unknown), Amanda E. Brinker, Prabhu Ramamoorthy, (unknown), (unknown), (unknown), (unknown), Michael J. McKenna, William McCulloch, Michael Dalton, Gregory A. Reed, Roy A. Jensen, (unknown), Shrikant Anant, John A. Taylor	17
8	Metastatic Tumor-in-a-Dish, a Novel Multicellular Organoid to Study Lung Colonization and Predict Therapeutic Response 2019 ·Cancer Research ·Prabhu Ramamoorthy, Sufi M. Thomas, Gaurav Kaushik, Dharmalingam Subramaniam, Katherine Chastain, Animesh Dhar, Ossama Tawfik, Anup Kasi, Weijing Sun, Satish Ramalingam, Sumedha Gunewardena, Shahid Umar, Joshua M.V. Mammen, Subhash Padhyé, Scott J. Weir, Roy A. Jensen, G. Sitta Sittampalam, Shrikant Anant	44
9	Targeted inhibition of histone deacetylase leads to suppression of Ewing sarcoma tumor growth through an unappreciated EWS-FLI1/HDAC3/HSP90 signaling axis 2019 ·Journal of Molecular Medicine ·Yan Ma, (unknown), (unknown), Jennifer Crow, (unknown), Vincent S. Staggs, Katherine Chastain, Jeffrey A. Toretsky, Scott J. Weir, Andrew K. Godwin	21
10	A phase I study of intraperitoneal nanoparticulate paclitaxel (Nanotax®) in patients with peritoneal malignancies 2015 ·Cancer Chemotherapy and Pharmacology ·Stephen K. Williamson, Gary A. Johnson, (unknown), Kathleen N. Moore, D. Scott McMeekin, Thomas K. Schulz, Gregory A. Reed, Katherine F. Roby, (unknown), H. John Smith, Scott J. Weir, Jo Wick, Maurie Markman, Gere S. diZerega, (unknown), (unknown), Charles J. Decedue	52
11	Drug Repurposing Identifies a Synergistic Combination Therapy with Imatinib Mesylate for Gastrointestinal Stromal Tumor 2014 ·Molecular Cancer Therapeutics ·Ziyan Y. Pessetto, Yan Ma, (unknown), Margaret von Mehren, Scott J. Weir, Andrew K. Godwin	32
12	Drug Repurposing for Gastrointestinal Stromal Tumor 2013 ·Molecular Cancer Therapeutics ·Ziyan Y. Pessetto, Scott J. Weir, Geetika Sethi, Melinda Broward, Andrew K. Godwin	82
13	CDK-4 Inhibitor P276 Sensitizes Pancreatic Cancer Cells to Gemcitabine-Induced Apoptosis 2012 ·Molecular Cancer Therapeutics ·Dharmalingam Subramaniam, Giridharan Periyasamy, Sivapriya Ponnurangam, (unknown), Aravind Sugumar, Muralidhara Padigaru, Scott J. Weir, Arun Balakrishnan, Somesh Sharma, Shrikant Anant	19
14	Gender-specific reduction of hepatic Mrp2 expression by high-fat diet protects female mice from ANIT toxicity 2012 ·Toxicology and Applied Pharmacology ·Bo Kong, Iván L. Csanaky, Lauren M. Aleksunes, (unknown), Qi Chen, Xiaochao Ma, Hartmut Jaeschke, Scott J. Weir, Melinda Broward, Curtis D. Klaassen, Grace L. Guo	15
15	The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy 2010 ·Journal of Clinical Pharmacy and Therapeutics ·Scott J. Weir, (unknown), Katherine D. Castle, (unknown), (unknown), Aaron D. Schimmer	30
16	Pharmacokinetics of Rifapentine in Patients with Varying Degrees of Hepatic Dysfunction 1998 ·The Journal of Clinical Pharmacology ·Anther Keung, Mark G. Eller, Scott J. Weir	14
17	Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers 1998 ·Clinical Pharmacology & Therapeutics ·Tanya L. Russell, M. Stoltz, Scott J. Weir	106
18	PHARMACOKINETICS OF MDL 26 479, A NOVEL BENZODIAZEPINE INVERSE AGONIST, IN NORMAL VOLUNTEERS 1997 ·Biopharmaceutics & Drug Disposition ·(unknown), (unknown), (unknown), (unknown), Vijay O. Bhargava, Scott J. Weir	8
19	The effect of food on the relative bioavailability of deflazacort 1996 ·European Journal of Drug Metabolism and Pharmacokinetics ·(unknown), Mark G. Eller, Thangam Arumugham, Scott J. Weir	6
20	Pharmacokinetics and pharmacodynamics of intravenous diltiazem in atrial fibrillation flutter af fl 1990 ·Clinical Pharmacology & Therapeutics ·Virgil C. Dias, Scott J. Weir, Kenneth A. Ellenbogen	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact